160 related articles for article (PubMed ID: 28017725)
1. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Ishida S; Kasamatsu A; Endo-Sakamoto Y; Nakashima D; Koide N; Takahara T; Shimizu T; Iyoda M; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Jan; 483(1):339-345. PubMed ID: 28017725
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
[TBL] [Abstract][Full Text] [Related]
3. Cavin-2 in oral cancer: A potential predictor for tumor progression.
Unozawa M; Kasamatsu A; Higo M; Fukumoto C; Koyama T; Sakazume T; Nakashima D; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
[TBL] [Abstract][Full Text] [Related]
4. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
5. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
7. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
[TBL] [Abstract][Full Text] [Related]
8. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cell transforming sequence 2 in human oral cancer.
Iyoda M; Kasamatsu A; Ishigami T; Nakashima D; Endo-Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2010 Nov; 5(11):e14082. PubMed ID: 21124766
[TBL] [Abstract][Full Text] [Related]
10. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.
Li M; Zhang Y; Bharadwaj U; Zhai QJ; Ahern CH; Fisher WE; Brunicardi FC; Logsdon CD; Chen C; Yao Q
Clin Cancer Res; 2009 Oct; 15(19):5993-6001. PubMed ID: 19755388
[TBL] [Abstract][Full Text] [Related]
12. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
[TBL] [Abstract][Full Text] [Related]
13. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
[TBL] [Abstract][Full Text] [Related]
14. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2b receptor promotes progression of human oral cancer.
Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921
[TBL] [Abstract][Full Text] [Related]
17. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
Baba T; Sakamoto Y; Kasamatsu A; Minakawa Y; Yokota S; Higo M; Yokoe H; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2015 Aug; 54(8):608-17. PubMed ID: 24375483
[TBL] [Abstract][Full Text] [Related]
18. [Effect of zinc on mRNA expression of ZIP4 in Caco2 cells].
Shen H; Qin HH; Long JG; Wang FD
Wei Sheng Yan Jiu; 2006 Jul; 35(4):426-7. PubMed ID: 16986515
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression.
Li M; Zhang Y; Liu Z; Bharadwaj U; Wang H; Wang X; Zhang S; Liuzzi JP; Chang SM; Cousins RJ; Fisher WE; Brunicardi FC; Logsdon CD; Chen C; Yao Q
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18636-41. PubMed ID: 18003899
[TBL] [Abstract][Full Text] [Related]
20. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer.
Cui X; Zhang Y; Yang J; Sun X; Hagan JP; Guha S; Li M
Cell Cycle; 2014; 13(7):1180-6. PubMed ID: 24553114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]